Logo image of SGHC

SUPER GROUP SGHC LTD (SGHC) Stock Fundamental Analysis

NYSE:SGHC - New York Stock Exchange, Inc. - GG00BMG42V42 - Common Stock - Currency: USD

11.39  +0.47 (+4.3%)

After market: 11.488 +0.1 (+0.86%)

Fundamental Rating

6

Taking everything into account, SGHC scores 6 out of 10 in our fundamental rating. SGHC was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and the financial health of SGHC get a neutral evaluation. Nothing too spectacular is happening here. SGHC is not overvalued while it is showing excellent growth. This is an interesting combination. This makes SGHC very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SGHC had positive earnings in the past year.
Of the past 5 years SGHC 4 years were profitable.
SGHC had a positive operating cash flow in each of the past 5 years.
SGHC Yearly Net Income VS EBIT VS OCF VS FCFSGHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.55%, SGHC belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
SGHC has a better Return On Equity (21.14%) than 78.95% of its industry peers.
The Return On Invested Capital of SGHC (30.47%) is better than 96.99% of its industry peers.
SGHC had an Average Return On Invested Capital over the past 3 years of 15.85%. This is above the industry average of 13.81%.
The last Return On Invested Capital (30.47%) for SGHC is above the 3 year average (15.85%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.55%
ROE 21.14%
ROIC 30.47%
ROA(3y)10.28%
ROA(5y)17.17%
ROE(3y)18.08%
ROE(5y)62.11%
ROIC(3y)15.85%
ROIC(5y)32.78%
SGHC Yearly ROA, ROE, ROICSGHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

SGHC's Profit Margin of 7.43% is fine compared to the rest of the industry. SGHC outperforms 62.41% of its industry peers.
In the last couple of years the Profit Margin of SGHC has declined.
With a decent Operating Margin value of 14.99%, SGHC is doing good in the industry, outperforming 66.17% of the companies in the same industry.
SGHC's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.99%
PM (TTM) 7.43%
GM N/A
OM growth 3Y-6.41%
OM growth 5YN/A
PM growth 3Y-26.17%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGHC Yearly Profit, Operating, Gross MarginsSGHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SGHC is creating value.
SGHC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SGHC has been increased compared to 5 years ago.
Compared to 1 year ago, SGHC has a worse debt to assets ratio.
SGHC Yearly Shares OutstandingSGHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SGHC Yearly Total Debt VS Total AssetsSGHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 9.78 indicates that SGHC is not in any danger for bankruptcy at the moment.
SGHC's Altman-Z score of 9.78 is amongst the best of the industry. SGHC outperforms 94.74% of its industry peers.
SGHC has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
SGHC's Debt to Equity ratio of 0.11 is amongst the best of the industry. SGHC outperforms 81.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 9.78
ROIC/WACC3.34
WACC9.12%
SGHC Yearly LT Debt VS Equity VS FCFSGHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

SGHC has a Current Ratio of 1.42. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
SGHC has a better Current ratio (1.42) than 70.68% of its industry peers.
SGHC has a Quick Ratio of 1.42. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
SGHC's Quick ratio of 1.42 is fine compared to the rest of the industry. SGHC outperforms 75.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
SGHC Yearly Current Assets VS Current LiabilitesSGHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 173.29% over the past year.
The earnings per share for SGHC have been decreasing by -16.35% on average. This is quite bad
SGHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.27%.
The Revenue has been growing by 28.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)173.29%
EPS 3Y-16.35%
EPS 5YN/A
EPS Q2Q%673.33%
Revenue 1Y (TTM)24.27%
Revenue growth 3Y8.72%
Revenue growth 5Y28.95%
Sales Q2Q%36.32%

3.2 Future

The Earnings Per Share is expected to grow by 37.35% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.48% on average over the next years. This is quite good.
EPS Next Y88.61%
EPS Next 2Y51.28%
EPS Next 3Y37.35%
EPS Next 5YN/A
Revenue Next Year20.89%
Revenue Next 2Y14.96%
Revenue Next 3Y12.48%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SGHC Yearly Revenue VS EstimatesSGHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
SGHC Yearly EPS VS EstimatesSGHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

SGHC is valuated rather expensively with a Price/Earnings ratio of 24.23.
Compared to the rest of the industry, the Price/Earnings ratio of SGHC indicates a somewhat cheap valuation: SGHC is cheaper than 65.41% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.45, SGHC is valued at the same level.
The Price/Forward Earnings ratio is 14.31, which indicates a correct valuation of SGHC.
75.94% of the companies in the same industry are more expensive than SGHC, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.90. SGHC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.23
Fwd PE 14.31
SGHC Price Earnings VS Forward Price EarningsSGHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SGHC.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.82
SGHC Per share dataSGHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

SGHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SGHC has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SGHC's earnings are expected to grow with 37.35% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y51.28%
EPS Next 3Y37.35%

2

5. Dividend

5.1 Amount

SGHC has a Yearly Dividend Yield of 1.40%.
Compared to an average industry Dividend Yield of 3.70, SGHC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, SGHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.4%

5.2 History

SGHC does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SGHC Yearly Dividends per shareSGHC Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y51.28%
EPS Next 3Y37.35%
SGHC Yearly Income VS Free CF VS DividendSGHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

SUPER GROUP SGHC LTD

NYSE:SGHC (7/3/2025, 8:08:53 PM)

After market: 11.488 +0.1 (+0.86%)

11.39

+0.47 (+4.3%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-05 2025-08-05
Inst Owners8.74%
Inst Owner Change7.06%
Ins Owners4.59%
Ins Owner ChangeN/A
Market Cap5.76B
Analysts85
Price Target12.07 (5.97%)
Short Float %2.25%
Short Ratio3.02
Dividend
Industry RankSector Rank
Dividend Yield 1.4%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date06-23 2025-06-23 (0.04)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.37%
Min EPS beat(2)-23.38%
Max EPS beat(2)16.64%
EPS beat(4)2
Avg EPS beat(4)-2.61%
Min EPS beat(4)-24.38%
Max EPS beat(4)20.66%
EPS beat(8)4
Avg EPS beat(8)53.07%
EPS beat(12)5
Avg EPS beat(12)27.75%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)6.35%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)13.79%
Revenue beat(4)2
Avg Revenue beat(4)4.08%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)13.79%
Revenue beat(8)6
Avg Revenue beat(8)5.4%
Revenue beat(12)9
Avg Revenue beat(12)4.58%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.63%
PT rev (3m)7.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.81%
EPS NY rev (1m)2.06%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.34%
Revenue NY rev (1m)2.71%
Revenue NY rev (3m)9.86%
Valuation
Industry RankSector Rank
PE 24.23
Fwd PE 14.31
P/S 2.66
P/FCF N/A
P/OCF N/A
P/B 7.58
P/tB 13.58
EV/EBITDA 13.82
EPS(TTM)0.47
EY4.13%
EPS(NY)0.8
Fwd EY6.99%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.28
BVpS1.5
TBVpS0.84
PEG (NY)0.27
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.55%
ROE 21.14%
ROCE 38.57%
ROIC 30.47%
ROICexc 30.47%
ROICexgc 50.76%
OM 14.99%
PM (TTM) 7.43%
GM N/A
FCFM N/A
ROA(3y)10.28%
ROA(5y)17.17%
ROE(3y)18.08%
ROE(5y)62.11%
ROIC(3y)15.85%
ROIC(5y)32.78%
ROICexc(3y)21.16%
ROICexc(5y)N/A
ROICexgc(3y)71.43%
ROICexgc(5y)N/A
ROCE(3y)20.07%
ROCE(5y)41.49%
ROICexcg growth 3Y-50.54%
ROICexcg growth 5YN/A
ROICexc growth 3Y-26.74%
ROICexc growth 5YN/A
OM growth 3Y-6.41%
OM growth 5YN/A
PM growth 3Y-26.17%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 0.19
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 9.78
F-ScoreN/A
WACC9.12%
ROIC/WACC3.34
Cap/Depr(3y)74.8%
Cap/Depr(5y)56.21%
Cap/Sales(3y)4%
Cap/Sales(5y)3.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)173.29%
EPS 3Y-16.35%
EPS 5YN/A
EPS Q2Q%673.33%
EPS Next Y88.61%
EPS Next 2Y51.28%
EPS Next 3Y37.35%
EPS Next 5YN/A
Revenue 1Y (TTM)24.27%
Revenue growth 3Y8.72%
Revenue growth 5Y28.95%
Sales Q2Q%36.32%
Revenue Next Year20.89%
Revenue Next 2Y14.96%
Revenue Next 3Y12.48%
Revenue Next 5YN/A
EBIT growth 1Y205.38%
EBIT growth 3Y1.74%
EBIT growth 5YN/A
EBIT Next Year91.04%
EBIT Next 3Y32.21%
EBIT Next 5YN/A
FCF growth 1Y141.86%
FCF growth 3Y4.65%
FCF growth 5Y301.24%
OCF growth 1Y113.19%
OCF growth 3Y13.51%
OCF growth 5Y143.31%